Key Highlights
•
A study of RSV vaccines found that maternal vaccination and infant nirsevimab, given alone or in combination, are safe and provide high neutralizing antibody levels in infants. This approach shows promise for preventing severe RSV infections in newborns and young children.
Source →
•
Research on human respiratory syncytial virus in adults in Georgia, USA (2024–2025) tracked the virus in both vaccinated and unvaccinated populations. This data is critical for understanding the real-world impact of RSV vaccination programs on adult infection rates.
Source →
•
A scoping review identified that language barriers create significant safety risks at multiple stages of pediatric emergency care, especially during discharge and follow-up instructions. This underscores a critical public health need for effective communication strategies, such as professional interpretation services, to ensure safe care delivery for all families.
Source →
Stay curious. Stay informed —
Science Briefing
